Aquestive Therapeutics, Inc.
AQST
$4.06
$0.041.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -6.12% | 113.20% | -11.83% | -4.04% | -8.15% |
| Total Receivables | 50.52% | -0.53% | 13.60% | 42.21% | -24.16% |
| Inventory | -21.75% | -2.97% | 12.88% | 19.09% | -13.92% |
| Prepaid Expenses | 42.50% | 144.57% | -58.33% | -12.66% | 66.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -1.58% | 85.60% | -8.35% | 1.08% | -8.65% |
|
|
|||||
| Total Current Assets | -1.58% | 85.60% | -8.35% | 1.08% | -8.65% |
| Net Property, Plant & Equipment | -1.99% | -0.94% | -0.92% | -1.46% | -1.93% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -17.41% | -0.28% | -23.89% | -0.19% | -0.17% |
| Total Assets | -1.92% | 74.56% | -8.35% | 0.80% | -7.76% |
|
|
|||||
| Total Accounts Payable | 174.85% | -9.09% | -2.68% | 19.37% | 35.86% |
| Total Accrued Expenses | -11.60% | 6.04% | 57.66% | -43.23% | 19.28% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 53.36% | 84.89% | 560.85% | 5.78% | 5.72% |
| Total Finance Division Other Current Liabilities | 0.00% | 0.00% | 2.15% | 0.00% | 0.00% |
| Total Other Current Liabilities | 0.00% | 0.00% | 2.15% | 0.00% | 0.00% |
| Total Current Liabilities | 86.16% | 10.45% | 26.54% | -3.01% | 24.51% |
|
|
|||||
| Total Current Liabilities | 86.16% | 10.45% | 26.54% | -3.01% | 24.51% |
| Long-Term Debt | -8.09% | -5.98% | -5.64% | 3.88% | 4.03% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.89% | -3.50% | -3.27% | -3.01% | -2.81% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.48% | 0.96% | 0.30% | 1.00% | 1.33% |
| Total Liabilities | 15.76% | 0.83% | 1.91% | 0.98% | 3.99% |
|
|
|||||
| Common Stock & APIC | 0.56% | 25.66% | 0.58% | 7.31% | 0.77% |
| Retained Earnings | -7.67% | -3.86% | -3.51% | -6.31% | -4.93% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -719.23% | 94.34% | -19.14% | -1.29% | -32.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -719.23% | 94.34% | -19.14% | -1.29% | -32.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -719.23% | 94.34% | -19.14% | -1.29% | -32.44% |
|
|
|||||